Cryopreservation preserves hematopoietic progenitor cells (HPC) for future use, but the freezing and thawing processes can impact viability. To ensure sufficient viable cells for downstream applications, post-thaw viability testing is essential. This session focuses on standardizing post-thaw viability testing methods, including thawing procedures and viability testing, with an emphasis on CAP proficiency testing and staff training.
Explain the importance of post-thaw viability testing and the benefits of standardization in maintaining the quality of cryopreserved cell products.
Identify optimal thawing conditions for specific cell types and implement standard thawing procedures to ensure the highest post-thaw viability.
Select appropriate viability testing methods for specific cell types and applications, and participate in CAP proficiency testing programs to evaluate and benchmark laboratory performance, ultimately improving the quality control of cryopreserved cell products.
Vice President Clinical Services,
MD, PhD, CABP(H),
MedStar Georgetown University Hospital